1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]
 
IJPMBS 2026 Vol.15(4): 188-191
doi: 10.18178/ijpmbs.15.4.188-191

The Review of Epigenetic and Genetic Limits to Indefinite Mammalian Cloning

Zhuoling Zhan
Chengdu No.7 High School, Chengdu, China
Email: 19302851784@163.com

Manuscript received September 15, 2026; accepted October 20, 2026; published November 17, 2026.

Abstract—Cloning via Somatic Cell Nuclear Transfer (SCNT) represents a landmark biotechnology with transformative implications for regenerative medicine and developmental biology. Beginning with the principle of cellular totipotency established by Gurdon’s nuclear transplantation experiments and culminating in the generation of Dolly the sheep. However, despite its promise, mammalian cloning remains constrained by fundamental biological barriers. Serial cloning studies in mice and pigs reveal progressive epigenetic degradation across successive generations—including aberrant DNA remethylation, histone modification defects, and imprinting disruptions that compromise embryonic genome activation and developmental competence—and these observations align closely with Muller’s ratchet, which predicts the irreversible accumulation of deleterious mutations in asexual lineages, ultimately driving mutational meltdown and extinction. Notably, a single round of sexual reproduction effectively resets these epigenetic lesions, underscoring the evolutionary indispensability of genetic recombination. This paper reviews the theoretical foundations, historical milestones, and persistent limitations of mammalian cloning, tracing its evolution from a proof of concept to a tool with therapeutic applications, and further examines the mechanistic basis of SCNT inefficiency, particularly the retention of hypermethylated states that suppress key pluripotency genes. Collectively, these findings elucidate the intrinsic limits of clonal propagation and emphasize the need for refined epigenetic modulation strategies to improve cloning efficiency and support responsible clinical and conservation applications.
 
Keywords—totipotency, clone, somatic cell nuclear transfer, serial cloning, muller’s ratchet

Cite: Zhuoling Zhan, "The Review of Epigenetic and Genetic Limits to Indefinite Mammalian Cloning," International Journal of Pharma Medicine and Biological Sciences, Vol. 15, No. 4, pp. 188-191, 2026.

Copyright © 2026 by the authors. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Copyright © 2012-2026. International Journal of Pharma Medicine and Biological Sciences. Unless otherwise stated.
​E-mail: ijpmbs@ejournal.net
Published by